) The Transgenic Mouse Shared Resource provides five services related to the production and maintenance of transgenic and knock-out mouse lines. These include: 1) The production of new lines of transgenic mice for SACI members. Investigators provide the core with a plasmid containing the desired transgene and a detailed plasmid map. The core is responsible for isolation of the transgene fragment and the production and identification of transgenic founder mice. At least two founder mice are produced for each transgene. 2) Mouse line rederivation by embryo transfer to eliminate pathogens from mice which have been obtained from outside, non-commercial sources. This method is highly effective and greatly reduces the cost and time involved in the quarantine approach to pathogen elimination. 3) Mouse lime embryo cryopreservation. This approach provides the means to preserve lines of mice without active breeding as well as safeguarding against the loss of mouse lines due to disease. 4) Blastocyst injection of embryonic stem (ES) cells for the production of knock-out mouse lines. This represents a new service to be added to the Transgenic Mouse Shared Resource Investigators provide the core with ES cell lines in which a specific gene has been disrupted by a homologous recombination. The core microinjects these cells into mouse blastocysts to produce chimeric mice. The core will also coordinate with a developing ES and feeder cell lines, targeting vectors, protocols and advice on ES cell culturing and manipulation. 5) Consulting services. The core staff provides advice on general transgenic and knock-out approaches and plasmid construction. For laboratories lacking experience with transgenic mice, instruction is provided on breeding of mice, weaning, ear punching, and tail DNA isolation. The core also provides assistance in preparing applications to the UTHSCSA IACUC for the use of laboratory animals in research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA054174-08
Application #
6102675
Study Section
Project Start
1998-08-06
Project End
1999-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Ctrc Research Foundation
Department
Type
DUNS #
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Yu, Xiaojie; Zhang, Yiqiang; Ma, Xiuye et al. (2018) miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer. Cancer Lett 427:85-93
Ankerst, Donna P; Goros, Martin; Tomlins, Scott A et al. (2018) Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. Eur Urol Focus :
Arora, Sukeshi Patel; Mahalingam, Devalingam (2018) Immunotherapy in colorectal cancer: for the select few or all? J Gastrointest Oncol 9:170-179
Arellano, Luisa M; Arora, Sukeshi Patel (2018) Systemic Treatment of Advanced Hepatocellular Carcinoma in Older Adults. J Nat Sci 4:
Du, Liqin; Zhao, Zhenze; Suraokar, Milind et al. (2018) LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer. Oncotarget 9:29601-29618
Ankerst, Donna P; Straubinger, Johanna; Selig, Katharina et al. (2018) A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. Eur Urol 74:197-203
Sun, Xiujie; Gupta, Kshama; Wu, Bogang et al. (2018) Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice. J Biol Chem 293:2841-2849
Horning, Aaron M; Wang, Yao; Lin, Che-Kuang et al. (2018) Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response. Cancer Res 78:853-864
Gong, Siqi; Tomusange, Khamis; Kulkarni, Viraj et al. (2018) Anti-HIV IgM protects against mucosal SHIV transmission. AIDS 32:F5-F13
Soteros, Breeanne M; Cong, Qifei; Palmer, Christian R et al. (2018) Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene. PLoS One 13:e0199399

Showing the most recent 10 out of 989 publications